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Schwann cells (SC) are characterized by a remarkable plasticity that enables them to promptly respond to nerve
injury promoting axonal regeneration. In peripheral nerves after damage SC convert to a repair-promoting phe-
notype activating a sequence of supportive functions that drive myelin clearance, prevent neuronal death, and
help axon growth and guidance. Regeneration of peripheral nerves after damage correlates inversely with
thrombin levels. Thrombin is not only the key regulator of the coagulation cascade but also a protease with hor-
mone-like activities that affects various cells of the central and peripheral nervous system mainly through the
protease-activated receptor 1 (PAR1). Aim of the present study was to investigate if and how thrombin could
affect the axon supportive functions of SC. In particular, our results show that the activation of PAR1 in rat SC
cultures with low levels of thrombin or PAR1 agonist peptides induces the release of molecules, which favor
neuronal survival and neurite elongation. Conversely, the stimulation of SC with high levels of thrombin or
PAR1 agonist peptides drives an opposite effect inducing SC to release factors that inhibit the extension of neu-
rites. Moreover, high levels of thrombin administered to sciatic nerve ex vivo explants induce a dramatic change
in SC morphology causing disappearance of the Cajal bands, enlargement of the Schmidt-Lanterman incisures
and calcium-mediated demyelination of the paranodes. Our results indicate thrombin as a novel modulator of
SC plasticity potentially able to favor or inhibit SC pro-regenerative properties according to its level at the site
of lesion.
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Introduction
The strong regenerative potential of peripheral nerves is main-
ly due to the ability of Schwann cells (SC) to convert to a repair-
promoting phenotype, which encourages axon growth (for a recent
review see1). Unfortunately, nerve stumps distal to transection
maintain full or mildly reduced capacity for supporting regenera-
tion only for about 1 month. Fading of the SC repair phenotype
occurs in chronic denervation and is amplified in aging.2-4
The lesion of a peripheral nerve is accompanied by a local dra-
matic increase in thrombin activity respect to the uninjured
control.5,6 Circulating concentration of prothrombin in normal sub-
jects ranges from 700 nM to 1.7 µM.7 It is also worth noting that
both thrombin and the extrinsic pathway FX/FXa are locally gen-
erated in sciatic nerve.8 In the peripheral nervous system (PNS),
low concentrations of thrombin were found to enhance the regen-
eration of mouse peripheral nerve after its crushing,9 while high
concentrations had deleterious effects.10 Accordingly, in the central
nervous system (CNS) thrombin is neuroprotective against
ischemia at low concentration but causes degeneration at high con-
centration.11 Thrombin is the key effector protease of the coagula-
tion cascade mediating hemostasis, thrombosis, and inflammatory
responses to vascular injury predominantly through the protease-
activated receptor 1 (PAR1).12 It is well known that SC primary
cultures release factors that promote the viability and neuritogene-
sis of neuronal cells.13 In this connection, our previous data indi-
cate that the activation of PAR1 by low levels of specific agonist
peptides in SC cultures enhances their ability to release molecules
(such as decorin and macrophage migration inhibitory factor, MIF)
that favor neuronal survival and neurite extension.14 PAR1 is the
main thrombin receptor and acts as a biosensor translating the
dynamic changes in the proteolytic microenvironment into cellular
responses. It is activated when thrombin cleaves its N-terminal
exodomain at a specific site. This cleavage event unmasks a new
N-terminus that then serves as a tethered ligand that binds
intramolecularly to the receptor effecting transmembrane signal-
ing. A synthetic agonist peptide (PAR1 AP) with a sequence corre-
sponding to the tethered ligand is able to stimulate PAR1 signalling
without the need of proteolytic activation.1 PAR1 is a G protein-
coupled receptor (GPCR) and its signaling is transduced via acti-
vation of phospholipase C (PLC), generation of inositol trisphos-
phate (IP3) and diacylglycerol (DAG), consecutive Ca2+ release
from intracellular stores, and protein kinase C (PKC) activation.
Unlike classic GPCRs, which are internalized and recycled back to
the cell surface after agonist stimulation, activated PAR1 is inter-
nalized and sorted from endosomes to lysosomes and degraded.
Internalization and lysosomal sorting is critical for terminating
activated PAR1 signaling.16 PAR1 is expressed within the blood
vascular system and throughout the CNS, predominantly in neu-
rons, microglia, astrocytes, and oligodendrocytes.11,17 PAR1 ago-
nists mediate oligodendrogliopathy18 and targeting this receptor
genetically or pharmacologically reduces its dysmyelinating
effects.19 In the PNS, PAR1 is present on the SC plasma membrane
and particularly concentrated at the level of the non-compacted SC
microvilli of the nodes of Ranvier.14,20
In the present study we compared the ability of low and high
levels of thrombin in modulating the SC neurotrophic properties in
cultures and the integrity of the nodes of Ranvier in sciatic nerve
ex vivo explants. To note high levels of thrombin or PAR1 AP
directly applied to rat sciatic nerve have been demonstrated to pro-
duce a rapid conduction block.20 Our data show that high and low
levels of thrombin displayed completely different actions inhibit-
ing the former and favoring the latter the ability of SC of support-
ing neuritogenesis. In addition, thrombin at high levels determined
a Ca2+-dependent paranodal demyelination of sciatic nerve fibers.
Materials and Methods
Materials
Collagenase type I, donkey serum, Hanks’ Balanced Salt
Solution (HBSS), hirudin, mouse monoclonal anti-S100b antibody
(AB_477499), poly-D-lysine hydrobromide, poly-L-ornithine
hydrobromide, Sudan black B, thapsigargin, thrombin, 0.25%
trypsin were from Sigma-Aldrich, Milan, Italy.
Advanced Dulbecco’s Modified Eagle Medium (Advanced
DMEM), fetal bovine serum, Fluo-4 AM (stock solution 1 mM in
DMSO), glycine, horse serum, N,N’-[1,2-ethanediylbis(oxy-2,1-
phenylene)]bis[N-[2-[(acetyloxy)methoxy]-2-oxoethyl]],
bis[(acetyloxy)methyl] ester (BAPTA-AM; stock solution 5 mM in
DMSO) were from Invitrogen, Monza, Italy.
Phosphate buffer saline (PBS) (0.1 g/L Ca2+ Chloride, 0.2 g/L
Potassium Chloride, 0.2 g/L Potassium Dihydrogen Phosphate, 0.1
g/L Magnesium Chloride Hexahydrate, 8 g/L Sodium Chloride,
2.1716 g/L Disodium Phosphate Heptahydrate) was from Corning.
The PAR1 activating peptide (PAR1 AP) TFLLR-NH2 was
from Bachem AG, Bubendorf, Switzerland.
Rabbit polyclonal antibody anti PAR1 (bs-0828R) was from
Bioss Antibodies Inc., Woburn, MA, USA.
SCH79797 (PAR1 selective antagonist) (stock solution 10 mM
in ethanol) was from Tocris Bioscience, Bristol, UK
Dylight 549-labelled anti-rabbit IgG and donkey AlexaFluor
488-labelled anti-mouse IgG were from Jackson ImmunoResearch
Laboratories,West Grove, PA, USA.
Affinity-purified goat anti-mouse IgG, Vectashield mounting
solution were from Vector Laboratories, Burlingame, CA, USA.
Preparation and treatments of primary Schwann cell
cultures
Schwann cells were isolated from the sciatic nerves of male
and female newborn Wistar rats and cultured as previously
described,21,22 with some modifications. All procedures involving
animals were carried out in accordance with the guidelines of the
European Communities Council Directive (86/609/EEC of 24
November 1986) and the Italian National law DL/116/92. All
methods used were carried out in accordance with guidelines of the
protocols n. 7FF2C.6.EXT.96 that has been approved by the
Ministry of Health (AMT, Aut. n. 1184/2016-PR 16/12/2016).
Briefly, the bilateral sciatic nerves were removed from 2- to 3-day-
old rats, minced with fine dissecting scissors into fragments,
digested twice with 0.25% trypsin and 1 mg/mL collagenase type
I in Advanced DMEM at 37°C for 30 min. Contaminating fibrob-
lasts were removed by immunopanning. Briefly tissue culture
plates were precoated with affinity-purified goat anti-mouse IgG
and then incubated with OX-7 hybridoma culture supernatant con-
taining anti-Thy1 IgG, which binds the cell surface molecule
Thy1.1 expressed on fibroblasts. Non-adherent cells were plated at
500-1000 cells/mm2 in petri dishes of 5 cm diameter (Falcon) pre-
coated with poly-D-lysine hydrobromide. Cells were cultured in
Advanced DMEM supplemented with 10% fetal bovine serum.
Cells were incubated at 37°C in a humidified 5% CO2 atmosphere
and medium was changed every three days. The cell preparation
consisted of 95% Schwann cells, as assessed by immunocytochem-
istry with anti-S100b antibody. Schwann cells were plated in 6-
well plates (7×105 cells/well) in 2 mL of Advanced DMEM supple-
mented with 10% fetal bovine serum. After 24 h cells were washed
three times in HBSS and then treated for 48 h in advanced DMEM
serum-free medium with thrombin (1, 10, 100 U/mL), the PAR1
activating peptide (PAR1 AP) (1, 10, 100 µM), hirudin (10, 100
U/mL), SCH79797 (1 µM) alone or in combination. The PAR1
specific inhibitor SCH79797 was added 5 min before PAR1 AP.
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PC12 neurite outgrowth and survival assays
The conditioned medium (CM) from Schwann cells was recov-
ered, spun, supplemented with 5% fetal bovine serum and 10%
horse serum and added to rat pheochromocytoma PC12 cells
(ECACC) for assessing neurite outgrowth. In fact, previously pub-
lished data indicate that Schwann cells release factors promoting
cell survival and neurite outgrowth of PC12 cells.13,14
PC12 cells were grown on coverslips precoated with poly-L-
ornithine hydrobromide in 24-well tissue culture plates. Cells were
seeded at low density (5×103 cells/well) to avoid contact inhibition
of neuritogenesis at higher densities. PC12 treated with nerve
growth factor (NGF; 50 ng/mL) were used as positive controls.
Medium was replaced every three days and after a week, PC12
cells were stained with hematoxylin and imaged with Nikon light
microscope (Eclipse E600; Nikon Instruments SpA, Florence,
Italy). The number of undifferentiated and neurite-extending cells
was determined by visual examination of the field and expressed
as the percentage of the total cells. Cells with neurites were defined
as cells that possessed at least one neurite with a length equal or
longer than the cell body diameter (12 μm is the mean diameter of
the control non-differentiated cells); 50-100 cells were assessed in
one experiment, and data are the means ± SE of three experiments.
For cell survival assays PC12 cells were seeded in 96-well
plates (2×104 cells/well) and after 24 h from seeding they were cul-
tured with the serum-free conditioned medium from Schwann cells
treated with thrombin (10, 100 U/mL) or PAR1 AP (10, 100 μM)
as mentioned above. Conditioned medium was replaced every
three days and after a week MTT assay was used to evaluate cell
viability. The MTT test measures the ability of living cells to
reduce MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
um bromide] into formazan crystals by the activity of mitochondr-
ial dehydrogenases. MTT assay was performed essentially as
described by Fabrizi et al.23 Briefly, 10 μL of MTT solution (5
mg/mL) was added to each well and the incubation was continued
for 3 h. Lysis buffer was prepared by dissolving 40% (w/v) SDS in
deionized water, after adding an equal volume of N,N dimethylfor-
mamide, and the pH was adjusted to 4.7. After a 3-h incubation
with MTT, 100 μL of the lysis buffer was added to each well and
the absorbance read at 570 nm on a microplate reader (Model 550
Microplate Reader, BioRad Laboratories, Hercules, CA, USA).
The relative cell viability (%) was expressed as a percentage rela-
tive to the untreated control cells.
In addition, cell viability was also assessed in the same sam-
ples by measuring the release of lactate dehydrogenase (LDH) in
the culture medium by the Cytotoxicity Detection Kit (Roche,
Mannheim, Germany) as previously described.24
Measurement of [Ca2+]i mobilization
Schwann cells seeded onto poli-L-lysine precoated chamber
slides (Ibidi, Martinseried, Germany) were loaded with 1 µM of
the cytosolic Ca2+ indicator Fluo-4 AM at 37°C, 5% CO2 for 15
min in PBS pH 7.4 containing 25 mM glucose and 1% bovine
albumin. After dye loading, cells were washed three times and then
images were recorded using confocal microscope TCS-SP5 (Leica
Microsystems, Heidelberg, Germany). Fluorescence intensity vs.
time was quantified with LAS-X analysis software (Leica
Microsystems) and expressed as DF/F0. The mean fluorescence
value of all cells in one field measured at the start of the experi-
ment is F0 and F is the fluorescence intensity recorded in the same
field as the experiment runs.
Ex vivo nerve explants
Sciatic nerves were rapidly removed from female adult Wistar
rats (200-250 g) and cut in 4-mm long segments. The pieces of sci-
atic nerve were incubated free-floating in advanced DMEM at
37°C in 5% CO2 /95% humidified air atmosphere and treated for 30
min, 1 h and 2 h with: 1, 10, 100 U/mL of thrombin; 1, 10, 100 μM
PAR1 AP; 10, 100 U/mL hirudin; 1 mM SCH79797 (5 min pre-
treatment); 1 μM BAPTA-AM (30 min pre-treatment); 100 nM
thapsigargin alone or in combinations. At the end of the procedure
samples were fixed for 30 min at room temperature (RT) with 4%
paraformaldehyde in 0.12 M phosphate buffer, pH 7.4, washed in
PBS and teased on positively charged glass slides. For immunoflu-
orescence staining, teased fibers were blocked with 10% donkey
serum containing 0.2% gelatin and 0.3% Triton X-100 for 1 h at
RT and then incubated overnight at 4°C with rabbit anti-PAR1
(diluted 1:100) and mouse anti-S100b antibodies (diluted 1:1000).
After washings with PBS, nerve preparations were incubated with
donkey Dylight 549-labelled anti-rabbit IgG (diluted 1:400) and
donkey AlexaFluor 488-labelled anti-mouse IgG (diluted 1:400).
Negative controls were done by omission of the first antibody or
by replacing the primary antibody with an equivalent amount of
Igs purified from preimmune sera. After a final wash with PBS, the
preparations were overlaid with coverslips using Vectashield
mounting solution and imaged with confocal microscope TCS-SP5
(Leica Microsystems, Heidelberg, Germany). For Sudan black B
staining, teased fibers were immersed in 0.1% Sudan black B dilut-
ed in 70% ethanol for 20 min at RT. Slides were then washed three
times for 5 min each in PBS containing 0.02% Tween 20. After a
final wash with PBS, the preparations were overlaid with cover-
slips using Vectashield mounting solution and imaged with Nikon
light microscope (Eclipse E600; Nikon Instruments SpA).
Variable pressure-scanning electron microscope
Hydrated teased fibers from ex vivo nerve explants were
observed using a variable pressure-scanning electron microscope
(VP-SEM) (Hitachi SU-3500). VP-SEM combined with Peltier
coolstage control optimally allowed high-resolution imaging of
hydrated specimens under varying pressure conditions, limiting
water vapour loss through control of stage temperature. Hydrated
samples prepared as described in section above were directly
observed on positively charged glass slides without conductive
coating. A thin film of distilled water was deposited onto hydrated
samples at RT to limit water-loss during low vacuum procedures.
By appropriate control of chamber pressure and cooling tempera-
ture, particular attention has been paid to avoid the formation of
collapsed surface of the Ranvier nodes. All samples were observed
at an accelerating voltage of 6 kV with working distance between
5 and 6.2 mm and the correlative pressure/temperature were stabi-
lized at 50 Pa/-25°C before. 
By VP-SEM technique alterations in morphology and structure
of the nodes were observed in their native hydrated state to assess
minimal conformational changes of the nerves. Respect to conven-
tional scanning electron microscope (SEM), VP-SEM is less time-
consuming and less prone to create artifacts during processing.
Statistics 
All experiments were performed in triple if not otherwise stat-
ed and reproduced three times. Statistical analyses were conducted
using GraphPad Prism version 4.00 software. Comparisons were
analysed using one-way ANOVA with Bonferroni-corrected t-test.
A minimum statistical value P<0.05 was considered significant.
Results
As mentioned above, SC in culture release factors that enhance
neuronal survival and neurite extension13. Consistently with those
previous reports, in neuronal PC12 cell line only 21±4% of the
untreated cells bore neurites at 7 days while this percentage
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increased to 40±3% after addition of the conditioned medium of
SC primary cultures (CM-SC). NGF used as positive control led
the percentage of PC12 cells bearing neuritis to 88±9% (Figure
1A). We have previously shown that the neurotrophic properties of
SC primary cultures are augmented when PAR1 is activated by low
levels of specific agonist peptides (PAR1 AP).14 Here we broaden
those previous results expanding the range of concentrations of
PAR1 AP and using also thrombin which is the main PAR1 natural
ligand. Thus, following the same procedure of our previous
paper14, SC were treated with thrombin (1, 10, 100 U/mL) and
PAR1 AP (1, 10, 100 μM). After 48 h CM-SC was transferred to
PC12 cells and neurite elongation was evaluated after 7 days. No
difference in neurite extension respect to controls was observed
using 1 μM PAR1 AP or 1 U/mL thrombin (not shown).
Conversely, CM obtained from SC treated with 10 μM PAR1 AP
or 10 U/mL of thrombin increased the percentage of PC12 cells
bearing neurites respect to controls (Figure 1 B,C). These results
are in line with our previous data.14 When we raised the level of the
PAR1 agonists we observed a completely different result. In fact,
CM obtained from SC treated with 100 U/mL of thrombin or 100
μM PAR1 AP determined a reduction in the number of PC12 cells
bearing neurites respect to controls (Figure 1 B,C). Thrombin was
inhibited by hirudin which occludes both the thrombin active site
and exosite I (fibrinogen and PAR1 recognition site) (Figure 1B).
Similarly the PAR1 specific inhibitor SCH79797 abolished the
effect of the PAR1 AP- treatment (Figure 1C).
The viability of PC12 cells was evaluated by MTT test in order
to check if thrombin or PAR1 AP treatments could determine the
release from SC of cytotoxic molecules. No difference in cell sur-
vival was measured in PC12 cells receiving CM from SC treated
with high levels of thrombin (100 U/mL) and PAR1 AP (100 μM)
(Figure 2). The same samples were tested for LDH release and no
statistically significant differences were measured respect to con-
trols (not shown). Conversely, CM from SC treated with low levels
of thrombin (10 U/mL) and PAR1 AP (10 μM) slightly increased
PC12 cell viability consistently with our previous data.14
PAR1 is a GPCR and its activation is known to determine a
rapid and transient rise in intracellular Ca2+ concentration.16 In SC
by increasing the concentration of thrombin from 10 to 100 U/ml,
we observed a parallel transient increase in intracellular Ca2+ lev-
els (Figure 3 A,B). A rapid rise in cytosolic Ca2+ levels was also
obtained using PAR1 AP (not shown). In order to check if the
ability of thrombin in modifying SC neurotrophic properties
could be calcium-mediated we used the intracellular Ca2+ chelator
BAPTA-AM. When this compound was administered to SC it
reverted the effect of both high and low levels of thrombin
(Figure 3C). As mentioned above, the main thrombin receptor
PAR1 is well expressed on the SC plasma membrane. While not
being evenly distributed, it appears concentrated at the level of
the nodes of Ranvier.14,20
In order to explore whether the activation of the
thrombin/PAR1 pathway could affect the SC/axon interaction in
nerve fibers, we moved to ex vivo explants of sciatic nerve where
the structure of the nodes of Ranvier are preserved. 
Nerve explants were cultured with different concentrations of
Figure 1. The conditioned medium from Schwann cells (CM-SC) stimulated with high or low levels of thrombin (or PAR1 AP) differ-
ently affects PC12 neurite outgrowth. A) PC12 cells were left untreated, treated with the culture medium from Schwann cells (CM-SC)
or treated with NGF for 7 days. B) PC12 cells were exposed for 7 days to the conditioned medium (CM-SC) from untreated Schwann
cells (ctrl) or from Schwann cells treated with: 10 U/mL thrombin; 100 U/mL thrombin; 10 U/mL hirudin + 10 U/mL thrombin; 100
U/mL hirudin + 100 U/mL thrombin; 100 U/mL hirudin alone; when SC were treated with 10 U /mL of thrombin their ability to pro-
mote neurite extension of PC12 was enhanced respect to the untreated SC while it was reduced with thrombin at 100 U/mL; thrombin
effect was inhibited by hirudin. C) PC12 cells were exposed for 7 days to the conditioned medium (CM-SC) from untreated Schwann
cells (ctrl) or from Schwann cells treated with 10, 100 mM PAR1 AP alone or in combination with 1 mM SCH79797; When SC were
treated with 10 mM PAR1 AP their ability to promote neurite extension of PC12 was enhanced respect to the untreated SC while it was
reduced with PAR1 AP at 100 mM; PAR1 AP was blocked by the PAR1 inhibitor SCH79797; the percentage of neurite-bearing cells
was calculated from 5 random fields per well, and the data are expressed as a mean percentage of 6 wells. Data are presented as mean
± SEM. °P≤0.05; *P≤0.01 respect to ctrl; **P≤0.001 respect to untreated.
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thrombin (1, 10, 100 U/mL) or PAR1 AP (1, 10, 100 μM) for 30 min,
1 h and 2 h. Then, nerve fibers were fixed, teased and stained for
PAR1 and the SC cytoplasmic marker S100b. In untreated nerve
explants PAR1 appeared mainly localized at the level of the nodes
while after 2 h of treatment with 100 U/mL of thrombin it became
more diffuse and scattered respect to the controls (Figure 4). To note,
together with PAR1, also the distribution of S100b was considerably
altered by thrombin treatment. In particular, in untreated nerve fibers
S100b labeled the characteristic network of anastomosing, cytoplas-
mic channels known as Cajal bands (Figure 5 A,B) and the Schmidt-
Lanterman incisures (SLI), another SC cytoplasmic compartment
(Figure 5C). The treatment with 1 and 10 U/mL of thrombin (or 1
and 10 μM of PAR1 AP) did not modify the morphology of the
fibers respect to the untreated controls up to 2 h (not shown).
Conversely, in fibers treated for 2 h with 100 U/mL of thrombin (or
100 μM PAR1 AP, not shown) we observed a completely different
distribution of the S100b staining characterized by the almost com-
plete disappearance of the Cajal bands (Figure 5 D,E) and the
marked dilation of the SLI (Figure 5F).  
In order to analyze if these changes in the cytoplasmic com-
partments of SC corresponded to any alteration in myelin distribu-
tion, we labeled myelin by Sudan black staining. By this method
we observed that nerve fibers treated with high concentrations of
thrombin or PAR1 AP (100 U/mL and 100 μM, respectively) were
characterized by an increased paranodal demyelination respect to
controls (Figure 6A, Table 1). Demyelination at the level of the
paranodes could also be observed at low percentage in untreated
controls and tended to increase with the time in culture (5±3% at
30 min, 8±2% at 1 h and 12±4% at 2 h). Alterations in the mor-
phology and structure of the nodes were analyzed in more detail by
electron microscopy. In particular, nerve fibers from ex vivo sciatic
nerve samples were directly observed using a VP-SEM, which
operates in a wet mode with no need of desiccation and coating.
Nerve fibers treated with high levels of thrombin or PAR1 AP and
analyzed by electron microscopy showed an evident displacement
of the SC at the nodes that consequently appeared elongated
(Figure 6B). No alteration in the morphology of the nodes was
observed with 1-10 U/mL thrombin or 1-10 μM PAR1 AP (not
shown). As shown in Table 1, the thrombin-induced paranodal
demyelination could be inhibited by hirudin, which blocks both the
PAR recognition and thrombin active sites. 
The thrombin-induced demyelinating effect was also impeded
by the intracellular calcium chelator BAPTA-AM (Table 1). Thus,
since the observed paranodal demyelination appeared to be calci-
um-related, we challenged nerve fibers with thapsigargin, a com-
pound known to induce an increase in cytosolic Ca2+ with a mech-
anism different from the one elicited by the activation of the throm-
bin/PAR1 axis. In fact, thapsigargin raises the intracellular Ca2+
concentration by blocking the endoplasmic reticulum Ca2+ ATPase
(SERCA) and activating plasma membrane Ca2+ channels25. 
Similarly to thrombin (100 U/mL), thapsigargin induced a pro-
Figure 2. The conditioned medium (CM) from thrombin-treated Schwann cells (SC) does not affect PC12 cell viability. PC12 cells were
exposed for 7 days to the CM of SC left untreated or treated with thrombin (10 and 100 U/mL) and PAR1 AP (10 and 100 mM). Cell
viability was evaluated by the MTT assay. Data are presented as mean ± SEM of three independent experiments. *P≤0.01 respect to the
untreated control.
Table 1. Percentage of paranodal demyelination in nerve fibers
following PAR1 overactivation. Ex vivo nerve explants were treat-
ed with: thrombin (1, 10, 100 U/mL), 100 U/mL hirudin + 
100 U/mL thrombin, 1 mM BAPTA AM + 100 U/mL thrombin;
PAR1 AP (1, 10, 100 μM), 1 mM BAPTA AM + 100 mM PAR1 AP,
1 mM SCH79797 + 100 mM PAR1 AP. After 30 min, 1 h and 2 h
of treatment samples were fixed, teased and stained by Sudan
black. The percentage of nodes of Ranvier showing demyelina-
tion was calculated from 5 random fields per well, and the data
are expressed as a mean percentage of 6 wells. Data are presented
as mean ± SEM.
                                                              30 min        1 h          2 h
Thrombin (THR)                                                                                                   
     0                                                                              5±3              8±2           12±4
     1 U/mL THR                                                          4±2              7±3             8±6
     10 U/mL THR                                                       6±3              7±5           12±5
     100 U/mL THR                                                   15±3*          30±5*        46±6*
     BAPTA AM + 100 U/mL THR                             6±2              5±3           11±4
     Hirudin + 100 U/mL THR                                  7±2             10±4          15±6
PAR 1 AP                                                                                                                   
     0                                                                              5±3              8±2           12±4
     1 mM PAR 1 AP                                                     6±4             11±5          10±3
     10 mM PAR 1 AP                                                   3±1              9±5           10±5
     100 mM PAR 1 AP                                             13±3*          25±4*        32±7*
     BAPTA AM + 100 mM PAR 1 AP                       4±2              7±4             9±3
     SCH79797+ 100 mM PAR 1 AP                         8±4             14±6          18±7
*P≤0.01 respect to control.
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Figure 4. Double immunofluorescence staining for PAR1 and S100b of fibers from ex vivo nerve explants after 2-h culture. A) PAR1
appears highly expressed at the level of the nodes of Ranvier in untreated control. B) After treatment with 100 U/mL of thrombin both
PAR1 and S100b are scattered and in clusters. Scale bar: 10 mm.
Figure 3. Thrombin dose-dependently induces an increase in intracellular Ca2+ levels in Schwann cells (SC). A) Representative tracings
of the cytosolic Ca2+ indicator dye Fluo4 after application of different doses of thrombin (10, 50, 100 U/mL) to SC; arrow points at the
stimulus administration; tracings indicate the mean fluorescence value of all cells in one field and are indicative of three independent
experiments. B) SC loaded with Fluo4 at time 0 and after 60 s from the application of 100 U/mL of thrombin; time 0 corresponds to
the stimulus administration (arrow in A). Phase contrast is shown on the right; scale bar: 50 mm. C) PC12 cells were exposed for 7 days
to the conditioned medium (CM-SC) from SC treated with 10 and 100 U/mL of thrombin alone or in combination with 1 mM BAPTA
AM. Data are presented as mean ± SEM. °P≤0.05; *P≤0.01 respect to samples left untreated or treated with vehicle alone.
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Figure 5. Immunofluorescence staining of fibers from ex vivo nerve explants for the SC cytosolic marker S100b. Thrombin-treatment
alters the morphology of both the Cajal bands and the Schmidt-Lanterman incisures (SLI). A) Control fibers left untreated for 2 h; scale
bar: 20 mm. B) Control fibers at higher magnification showing a node of Ranvier and the presence of Cajal bands (arrows); scale bar:
10 mm. C) Schmidt-Lanterman incisures (arrows) in control fibers left untreated for 2 h; phase contrast image on the right; scale bar:
10 mm. D) Nerve fibers treated for 2 h with 100 U/mL of thrombin (THR); scale bar: 20 μm. E) Nerve fibers treated for 2 h with 100
U/mL of thrombin (THR) at higher magnification showing the highly disorganized architecture of the Cajal bands; scale bar 10 mm.
F) Dilation of a Schmidt-Lanterman incisure (arrow) in nerve fibers treated for 2 h with 100 U/mL of thrombin (THR); phase contrast
image on the right; scale bar: 10 mm.
EJH_2020_02_original.qxp_Hrev_master  19/03/20  20:01  Pagina 110
No
n-c
om
me
rci
al 
us
e o
nly
                                                                                                                   Article
Figure 6. PAR1 overactivation determines in ex vivo nerve explants paranodal demyelination associated to a displacement of SC at the
level of the nodes. A) Nerve fibers treated for 2 h with 100 U/mL of thrombin (THR) or 100 mm PAR1 AP observed by Sudan black
staining are characterized by demyelination and myelin fragmentation at the level of the paranodes; scale bars: 10 mm. B) Nerve fibers
treated for 2 h with 100 U/mL of thrombin (THR) or 100 mm PAR1 AP observed by VP-SEM show displacement of SC in the nodal
region and elongated nodes; scale bars: 10 mm.
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nounced alteration in S100b and myelin distribution in nerve
fibers. When administered to ex vivo nerve explants this com-
pound determined extensive paranodal demyelination of nerve
fibers (57±6 % at 2 h) with concurrent enlargement of the SLI and
disappearance of Cajal bands. In addition, in thapsigargin-treated
samples demyelination appeared also in vast areas of the inter-
nodes (Figure 7). 
Discussion
In this paper we show that the activation of the
thrombin/PAR1 axis in SC profoundly affects two major proper-
ties of these cells that is their ability to promote neuritogenesis and
their capacity to maintain the integrity of the nodes of Ranvier.
When treated with low levels of thrombin SC in culture show
an enhanced ability to release factors promoting PC12 neurite
extension. This effect can be blocked by the administration of
hirudin, which inhibits the thrombin proteolyic activity, and it can
be reproduced by a specific PAR1 agonist peptide. These results
are consistent with our previous data indicating that the activation
of PAR1 induces the release from SC of molecules, which favor
neuronal survival and neurite extension such as decorin and MIF.14
Although it would be improper to directly translate these findings
in vivo, these data are in line with results obtained in vivo where
thrombin at low concentration was demonstrated to favor nerve
regeneration.9 As mentioned above, peripheral nerve damage is
accompanied by the increase in thrombin activity at the site of
injury.5,6 Thrombin activity was also found to be increased early in
the clinical course of experimental autoimmune neuritis (EAN) in
rat sciatic nerve.2 In our model system SC treated with high levels
of thrombin (100 U/mL) showed a reduced capacity of promoting
PC12 neurite extension respect to controls. This effect appeared
not related to the release of cytotoxic molecules from thrombin-
treated SC primary cultures. The different effect exerted by throm-
bin in cultures at low and high doses is not surprising since in
other systems this protease was reported to display different
actions according to its concentration.11
We observed divergent effects of low and high levels of
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thrombin on SC also in sciatic nerve ex vivo explants. In this model
system although the nerve is transected the three-dimensional rela-
tionship between SC and the axon is mainly maintained. Low lev-
els of thrombin in this model did not determine any evident modi-
fication in the morphology of SC and in particular of the nodes.
Conversely, high levels of thrombin (100 U/mL) or PAR1 AP (100
μM) induced a profound rearrangement of SC and in particular the
disappearance of the Cajal bands. Interestingly, a similar pattern of
alteration of the Cajal bands is observed after chronic nerve com-
pression.27 Studies using periaxin-null mice indicate that the Cajal
bands facilitate the microtubule-based transport of proteins and
organelles in SC and aberrations in their architecture compromises
myelin maintenance.28 Actually, our data show that nerve fibers
treated with high levels of PAR1 agonists present evident signs of
demyelination at the level of the paranodes. It is notable that PAR1
is mostly expressed on the microvilli of the SC, that is in close
proximity to the paranodes.14,20 In addition, thrombin (100-200
U/mL) and PAR1 AP (150-300 μM) cause a conduction failure in
sciatic nerve within 30 min of application.20
Our data indicate that the observed paranodal demyelination
induced after PAR1 overactivation is calcium-mediated. In con-
nection with this result, elevation of intracellular Ca2+ levels has
been reported to induce myelin basic protein (MBP) network dis-
assembly and myelin vesiculation in CNS.29 Besides, in
ischemia myelin is damaged in a calcium-dependent manner, abol-
ishing action potential propagation,30-32 and specific thrombin
inhibitors were shown to reduce neurological deficit in models of
middle cerebral artery occlusion.33 The beneficial effect of throm-
bin inhibition was recently reported to occur in EAN,25 and diabet-
ic neuropathy34 indicating the pathogenic importance of this path-
way also in the PNS.
Our results obtained with high levels of thrombin in SC cul-
tures and ex vivo nerve explants can be reproduced by PAR1 AP
and inhibited by the specific PAR1 antagonist SCH79797 indicat-
ing the involvement of PAR1 in these processes. Nevertheless, the
possibility of activation and transactivation of other members of
the PAR family cannot be completely ruled out. In particular,
thrombin in adequate concentrations is known to activate the
receptor for trypsin PAR235 and the low-affinity thrombin receptor
PAR4.36 However, in our SC cultures while thrombin and PAR1 AP
dose-dependently induce a consistent rise in cytosolic Ca2+, the
specific agonist peptides for PAR2 and PAR4 determine only neg-
ligible modifications of the intracellular Ca2+ levels (unpublished
observations). Our data contribute towards considering thrombin,
which appears deregulated at sites of PNS injury a possible novel
therapeutic target. Potentially a pharmacological reduction of its
excessive activity at the level of nerve lesions could circumvent
the demyelinating properties of this protease and restore the SC
neurotrophic activities. Nevertheless, the complete pathways,
which underlie thrombin deleterious or protective effect in PNS,
need further investigation before considering possible therapeutic
applications.
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